Elizabeth Holmes Rebuts Prosecution’s Key Argument In Trial

On Monday, Elizabeth Holmes, the founder of the blood testing start-up Theranos, aimed to rebut a key argument made by prosecutors in her fraud case: that she lied about her company’s work with pharmaceutical companies.

One of the most damning pieces of evidence prosecutors have presented against Ms. Holmes is that Theranos sent falsified pharmaceutical company validation reports to investors. Those reports displayed the logos of drug makers, which acted as proof that Theranos’s technology had been validated by them. During the trial, investors have testified that those reports helped persuade them to pour money into Ms. Holmes’s start-up.

But representatives from Pfizer and Schering-Plough testified that their companies had never validated Theranos’s technology. (Pfizer’s representative said the company had come to the opposite conclusion.) Nor had they approved of having their logos added to the reports.

On the stand on Monday, Ms. Holmes testified about studies that Theranos did with Merck, AstraZeneca, Centocor, Bristol Myers Squibb and others in 2008 and 2009. One exhibit displayed internal documentation about the success of some of this early work and showed a map of around a dozen cities around the world where Theranos’s machines were used for studies.

Kevin Downey, Ms. Holmes’s lawyer, also showed what he called a peer-reviewed journal that published the results of a study that Theranos did with Stanford University around this time. He did not mention the name of the journal.

In each example, Ms. Holmes’s understanding of Theranos’s technology was that “it performed well,” she testified. In some of the examples, Theranos was paid for its work in the studies.

Throughout her trial, Ms. Holmes’s defense team has tried making the case that there was some truth to what Ms. Holmes told investors.

“The reality of what happened at Theranos is far, far more complicated than what you have heard about Elizabeth Holmes so far,” Lance Wade, another of Ms. Holmes’s lawyers, said in his opening statement at the trial’s start in September.

Scalable information systems | A Research Paper By Hrishitva Patel

Name: Hrishitva Patel Email: hpatel51@binghamton.edu About the author- Hrishitva Patel is a researcher and a technology enthusiast. His fields of research interest include qualitative and quantitative research methods in the field of Management information systems and Computer science. He has a knack for chess and a passion for painting and reading books. Abstract Scalability is […]

Know More

Brewing Danger: How Your Coffee Maker Could Be Making You Sick

Shaping a Better Future: Prioritizing Health and Wellness The coffee industry is one of the largest and most complex agricultural industries in the world, with millions of farmers, traders, and roasters involved in the production and consumption of coffee. As the demand for coffee continues to rise, it’s important to consider what is being made […]

Know More

Microsoft Bets Big on the Creator of ChatGPT in Race to Dominate A.I.

OpenAI is led by Sam Altman, who became well known in Silicon Valley as the head the start-up builder Y Combinator. Mr. Altman, 37, and his co-founders created OpenAI in 2015 as a nonprofit. But he soon remade the venture as a for-profit company that could more aggressively pursue financing. A year later, Microsoft invested […]

Know More